Order Article Reprints

Manea S-A, Vlad M-L, Lazar A-G, Muresian H, Simionescu M, Manea A. Pharmacological Inhibition of Lysine-Specific Demethylase 1A Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice by a Mechanism Involving Decreased Oxidative Stress and Inflammation; Potential Implications in Human Atherosclerosis. Antioxidants. 2022; 11(12):2382. https://doi.org/10.3390/antiox11122382

Manea, Simona-Adriana, Mihaela-Loredana Vlad, Alexandra-Gela Lazar, Horia Muresian, Maya Simionescu, and Adrian Manea. 2022. "Pharmacological Inhibition of Lysine-Specific Demethylase 1A Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice by a Mechanism Involving Decreased Oxidative Stress and Inflammation; Potential Implications in Human Atherosclerosis" Antioxidants 11, no. 12: 2382. https://doi.org/10.3390/antiox11122382

Manea, S.-A., Vlad, M.-L., Lazar, A.-G., Muresian, H., Simionescu, M., & Manea, A. (2022). Pharmacological Inhibition of Lysine-Specific Demethylase 1A Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice by a Mechanism Involving Decreased Oxidative Stress and Inflammation; Potential Implications in Human Atherosclerosis. Antioxidants, 11(12), 2382. https://doi.org/10.3390/antiox11122382